129 related articles for article (PubMed ID: 24564251)
21. Decreased expression of miR-204 in plasma is associated with a poor prognosis in patients with non-small cell lung cancer.
Guo W; Zhang Y; Zhang Y; Shi Y; Xi J; Fan H; Xu S
Int J Mol Med; 2015 Dec; 36(6):1720-6. PubMed ID: 26497897
[TBL] [Abstract][Full Text] [Related]
22. Aberrant miR-181b-5p and miR-486-5p expression in serum and tissue of non-small cell lung cancer.
Tian F; Shen Y; Chen Z; Li R; Lu J; Ge Q
Gene; 2016 Oct; 591(2):338-43. PubMed ID: 27291819
[TBL] [Abstract][Full Text] [Related]
23. Methylation markers of early-stage non-small cell lung cancer.
Lokk K; Vooder T; Kolde R; Välk K; Võsa U; Roosipuu R; Milani L; Fischer K; Koltsina M; Urgard E; Annilo T; Metspalu A; Tõnisson N
PLoS One; 2012; 7(6):e39813. PubMed ID: 22768131
[TBL] [Abstract][Full Text] [Related]
24. MicroRNAs associated with increased AKT gene number in human lung carcinoma.
Goto A; Dobashi Y; Tsubochi H; Maeda D; Ooi A
Hum Pathol; 2016 Oct; 56():1-10. PubMed ID: 27189341
[TBL] [Abstract][Full Text] [Related]
25. Methylation of the DCLK1 promoter region in circulating free DNA and its prognostic value in lung cancer patients.
Powrózek T; Krawczyk P; Nicoś M; Kuźnar-Kamińska B; Batura-Gabryel H; Milanowski J
Clin Transl Oncol; 2016 Apr; 18(4):398-404. PubMed ID: 26311076
[TBL] [Abstract][Full Text] [Related]
26. Three circulating long non-coding RNAs act as biomarkers for predicting NSCLC.
Tang Q; Ni Z; Cheng Z; Xu J; Yu H; Yin P
Cell Physiol Biochem; 2015; 37(3):1002-9. PubMed ID: 26393913
[TBL] [Abstract][Full Text] [Related]
27. Peripheral blood miR-328 expression as a potential biomarker for the early diagnosis of NSCLC.
Ulivi P; Foschi G; Mengozzi M; Scarpi E; Silvestrini R; Amadori D; Zoli W
Int J Mol Sci; 2013 May; 14(5):10332-42. PubMed ID: 23681013
[TBL] [Abstract][Full Text] [Related]
28. Increased Plasma miRNA-30a as a Biomarker for Non-Small Cell Lung Cancer.
Sun L; Chen Y; Su Q; Tang X; Liang Y; Che G; Luo F
Med Sci Monit; 2016 Feb; 22():647-55. PubMed ID: 26918265
[TBL] [Abstract][Full Text] [Related]
29. A transcriptional miRNA-gene network associated with lung adenocarcinoma metastasis based on the TCGA database.
Wang Y; Han R; Chen Z; Fu M; Kang J; Li K; Li L; Chen H; He Y
Oncol Rep; 2016 Apr; 35(4):2257-69. PubMed ID: 26781266
[TBL] [Abstract][Full Text] [Related]
30. Identification and Integrated Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer.
Liu X; Liu X; Li J; Ren F
Med Sci Monit; 2019 Dec; 25():9280-9289. PubMed ID: 31805030
[TBL] [Abstract][Full Text] [Related]
31. Up-Regulation of miR-21 Expression Predicate Advanced Clinicopathological Features and Poor Prognosis in Patients with Non-Small Cell Lung Cancer.
Tian L; Shan W; Zhang Y; Lv X; Li X; Wei C
Pathol Oncol Res; 2016 Jan; 22(1):161-7. PubMed ID: 26453197
[TBL] [Abstract][Full Text] [Related]
32. Two microRNA panels to discriminate three subtypes of lung carcinoma in bronchial brushing specimens.
Huang W; Hu J; Yang DW; Fan XT; Jin Y; Hou YY; Wang JP; Yuan YF; Tan YS; Zhu XZ; Bai CX; Wu Y; Zhu HG; Lu SH
Am J Respir Crit Care Med; 2012 Dec; 186(11):1160-7. PubMed ID: 23043084
[TBL] [Abstract][Full Text] [Related]
33. The oncogenic and prognostic potential of eight microRNAs identified by a synergetic regulatory network approach in lung cancer.
Mitra R; Zhao Z
Int J Comput Biol Drug Des; 2014; 7(4):384-93. PubMed ID: 25539849
[TBL] [Abstract][Full Text] [Related]
34. Prognostic impact of a 3-MicroRNA signature in cytological samples of small cell lung cancer.
Mancuso G; Bovio E; Rena O; Rrapaj E; Mercalli F; Veggiani C; Paganotti A; Andorno S; Boldorini R
Cancer Cytopathol; 2016 Sep; 124(9):621-9. PubMed ID: 27153322
[TBL] [Abstract][Full Text] [Related]
35. Functional analysis of microRNA and transcription factor synergistic regulatory network based on identifying regulatory motifs in non-small cell lung cancer.
Li K; Li Z; Zhao N; Xu Y; Liu Y; Zhou Y; Shang D; Qiu F; Zhang R; Chang Z; Xu Y
BMC Syst Biol; 2013 Nov; 7():122. PubMed ID: 24200043
[TBL] [Abstract][Full Text] [Related]
36. Clinical value of miR-198-5p in lung squamous cell carcinoma assessed using microarray and RT-qPCR.
Liang YY; Huang JC; Tang RX; Chen WJ; Chen P; Cen WL; Shi K; Gao L; Gao X; Liu AG; Peng XT; Chen G; Huang SN; Fang YY; Gu YY
World J Surg Oncol; 2018 Feb; 16(1):22. PubMed ID: 29394946
[TBL] [Abstract][Full Text] [Related]
37. Circulating miR-125b is a novel biomarker for screening non-small-cell lung cancer and predicts poor prognosis.
Yuxia M; Zhennan T; Wei Z
J Cancer Res Clin Oncol; 2012 Dec; 138(12):2045-50. PubMed ID: 22806310
[TBL] [Abstract][Full Text] [Related]
38. Prediction of lung cancer based on serum biomarkers by gene expression programming methods.
Yu Z; Chen XZ; Cui LH; Si HZ; Lu HJ; Liu SH
Asian Pac J Cancer Prev; 2014; 15(21):9367-73. PubMed ID: 25422226
[TBL] [Abstract][Full Text] [Related]
39. Accurate classification of non-small cell lung carcinoma using a novel microRNA-based approach.
Bishop JA; Benjamin H; Cholakh H; Chajut A; Clark DP; Westra WH
Clin Cancer Res; 2010 Jan; 16(2):610-9. PubMed ID: 20068099
[TBL] [Abstract][Full Text] [Related]
40. A Five-miRNA Panel Identified From a Multicentric Case-control Study Serves as a Novel Diagnostic Tool for Ethnically Diverse Non-small-cell Lung Cancer Patients.
Wang C; Ding M; Xia M; Chen S; Van Le A; Soto-Gil R; Shen Y; Wang N; Wang J; Gu W; Wang X; Zhang Y; Zen K; Chen X; Zhang C; Zhang CY
EBioMedicine; 2015 Oct; 2(10):1377-85. PubMed ID: 26629532
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]